Doloproct

Doloproct is a rectal medication combining fluocortolone pivalate and lidocaine hydrochloride. It is commonly used for hemorrhoid relief and local pain management. This product is manufactured by Karo Pharma AB in the EU.

Doloproct is primarily used for the treatment of hemorrhoids and associated discomfort. The combination of fluocortolone pivalate and lidocaine hydrochloride works to reduce inflammation and provide local pain relief. This medication is applied rectally to target the affected area directly.

Users of Doloproct may experience reduced pain and inflammation in the rectal area. The lidocaine component provides a numbing effect, while the fluocortolone pivalate helps to decrease swelling and discomfort. These effects are typically localized to the application site.

Doloproct should be used as directed to avoid potential side effects. It is important to follow the instructions for rectal application carefully. Users should be aware of any allergic reactions to the ingredients and consult a healthcare professional if symptoms persist or worsen.

Doloproct may interact with other medications, particularly those that affect the rectal area. It is advisable to inform a healthcare provider about all current medications before using this product. Additionally, alcohol or other topical treatments should be used with caution to avoid adverse reactions.